Kimberly Kraig Thompson

This profile gathers the share dealings of Kimberly Kraig Thompson in Kraig Biocraft Laboratories, Inc, where the filings describe the role as chief executive. Between 3 May 2021 and 31 March 2025, the trades on record add up to 66 filings.

Sales make up the whole of the open-market record (64 sales). The totals do not cover 64 filings with an undisclosed amount.

Most recently, on 10 April 2025, the filings show a transaction worth €2,303 in Kraig Biocraft Laboratories, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.